These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30207377)

  • 1. Probing the interaction of a quercetin bioconjugate with Bcl-2 in living human cancer cells with in-cell NMR spectroscopy.
    Primikyri A; Sayyad N; Quilici G; Vrettos EI; Lim K; Chi SW; Musco G; Gerothanassis IP; Tzakos AG
    FEBS Lett; 2018 Oct; 592(20):3367-3379. PubMed ID: 30207377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct binding of Bcl-2 family proteins by quercetin triggers its pro-apoptotic activity.
    Primikyri A; Chatziathanasiadou MV; Karali E; Kostaras E; Mantzaris MD; Hatzimichael E; Shin JS; Chi SW; Briasoulis E; Kolettas E; Gerothanassis IP; Tzakos AG
    ACS Chem Biol; 2014 Dec; 9(12):2737-41. PubMed ID: 25211642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex disruption effect of natural polyphenols on Bcl-2-Bax: molecular dynamics simulation and essential dynamics study.
    Verma S; Singh A; Mishra A
    J Biomol Struct Dyn; 2015; 33(5):1094-106. PubMed ID: 24903407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insight into Functional Membrane Proteins by Solution NMR: The Human Bcl-2 Protein-A Promising Cancer Drug Target.
    Ul Mushtaq A; Ådén J; Sparrman T; Hedenström M; Gröbner G
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33800399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplifying and broadening the cytotoxic profile of quercetin in cancer cell lines through bioconjugation.
    Chatziathanasiadou MV; Geromichalou EG; Sayyad N; Vrettos EI; Katsikoudi A; Stylos E; Bellou S; Geromichalos GD; Tzakos AG
    Amino Acids; 2018 Feb; 50(2):279-291. PubMed ID: 29185031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear magnetic resonance study of protein-protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl-2 members.
    Santiveri CM; Sborgi L; de Alba E
    J Mol Recognit; 2012 Dec; 25(12):665-73. PubMed ID: 23192964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of lafutidine in binding to human serum albumin in gastric ulcer therapy: STD-NMR, WaterLOGSY-NMR, NMR relaxation times, Tr-NOESY, molecule docking, and spectroscopic studies.
    Yang H; Huang Y; He J; Li S; Tang B; Li H
    Arch Biochem Biophys; 2016 Sep; 606():81-9. PubMed ID: 27457418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL-2 Protein Family Interaction Analysis by Nuclear Magnetic Resonance Spectroscopy.
    Garner TP; Gavathiotis E
    Methods Mol Biol; 2019; 1877():217-231. PubMed ID: 30536009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enriching the biological space of natural products and charting drug metabolites, through real time biotransformation monitoring: The NMR tube bioreactor.
    Chatzikonstantinou AV; Chatziathanasiadou MV; Ravera E; Fragai M; Parigi G; Gerothanassis IP; Luchinat C; Stamatis H; Tzakos AG
    Biochim Biophys Acta Gen Subj; 2018 Jan; 1862(1):1-8. PubMed ID: 28974426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design and structure-activity relationship studies of quercetin-amino acid hybrids targeting the anti-apoptotic protein Bcl-xL.
    Kellici TF; Chatziathanasiadou MV; Lee MS; Sayyad N; Geromichalou EG; Vrettos EI; Tsiailanis AD; Chi SW; Geromichalos GD; Mavromoustakos T; Tzakos AG
    Org Biomol Chem; 2017 Sep; 15(37):7956-7976. PubMed ID: 28902204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutron reflectometry and NMR spectroscopy of full-length Bcl-2 protein reveal its membrane localization and conformation.
    Mushtaq AU; Ådén J; Clifton LA; Wacklin-Knecht H; Campana M; Dingeldein APG; Persson C; Sparrman T; Gröbner G
    Commun Biol; 2021 Apr; 4(1):507. PubMed ID: 33907308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of p53 peptide analogues to anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy.
    Shin JS; Ha JH; Chi SW
    Biochem Biophys Res Commun; 2014 Jan; 443(3):882-7. PubMed ID: 24342622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a potent and selective Bcl-2 inhibitor using SAR by NMR.
    Petros AM; Huth JR; Oost T; Park CM; Ding H; Wang X; Zhang H; Nimmer P; Mendoza R; Sun C; Mack J; Walter K; Dorwin S; Gramling E; Ladror U; Rosenberg SH; Elmore SW; Fesik SW; Hajduk PJ
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6587-91. PubMed ID: 20870405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design and real time, in-cell detection of the proapoptotic activity of a novel compound targeting Bcl-X(L).
    Becattini B; Kitada S; Leone M; Monosov E; Chandler S; Zhai D; Kipps TJ; Reed JC; Pellecchia M
    Chem Biol; 2004 Mar; 11(3):389-95. PubMed ID: 15123268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can the conformation of flexible hydroxyl groups be constrained by simple NMR crystallography approaches? The case of the quercetin solid forms.
    Filip X; Filip C
    Solid State Nucl Magn Reson; 2015 Feb; 65():21-8. PubMed ID: 25465481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for the conserved binding mechanism of MDM2-inhibiting peptides and anti-apoptotic Bcl-2 family proteins.
    Lee MS; Ha JH; Yoon HS; Lee CK; Chi SW
    Biochem Biophys Res Commun; 2014 Feb; 445(1):120-5. PubMed ID: 24491548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orthogonal
    Grage SL; Kara S; Bordessa A; Doan V; Rizzolo F; Putzu M; Kubař T; Papini AM; Chaume G; Brigaud T; Afonin S; Ulrich AS
    Chemistry; 2018 Mar; 24(17):4328-4335. PubMed ID: 29323432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments and applications of saturation transfer difference nuclear magnetic resonance (STD NMR) spectroscopy.
    Wagstaff JL; Taylor SL; Howard MJ
    Mol Biosyst; 2013 Apr; 9(4):571-7. PubMed ID: 23232937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of differential protein binding affinities in an atropisomeric pharmaceutical compound by noncovalent mass spectrometry, equilibrium dialysis, and nuclear magnetic resonance.
    Maple HJ; Garlish RA; Whitcombe I; Hold A; Prosser CE; Ford D; Mackenzie H; Crosby J; Porter J; Taylor RJ; Crump MP
    Anal Chem; 2013 Jun; 85(12):5958-64. PubMed ID: 23697870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the interactions and bioactivity of quercetin-(2-hydroxypropyl)-β-cyclodextrin complex.
    Kellici TF; Chatziathanasiadou MV; Diamantis D; Chatzikonstantinou AV; Andreadelis I; Christodoulou E; Valsami G; Mavromoustakos T; Tzakos AG
    Int J Pharm; 2016 Sep; 511(1):303-311. PubMed ID: 27395802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.